Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Patients need better counseling and resources for managing chemotherapy-induced hair loss.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Bhringaraj extract tablets significantly reduce hair fall and are well-tolerated.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Combining psychodermatology and PRP therapy can improve skin condition treatment by addressing both mental and physical health.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Adaptive coping reduces PCOS symptoms, while maladaptive coping worsens them.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

The approach improves scalp surgery results by tailoring techniques to defect size and location.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Nearly all elderly nursing home residents had a skin disease, with dry skin being the most common.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Menopause affects hair and skin; more research needed for treatment.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.